Results 41 to 50 of about 4,210,891 (389)

Evaluating the Supporting Evidence of Medical Cannabis Claims Made on Clinic Websites: Cross-Sectional Study

Journal of Medical Internet Research, 2023
BackgroundSince the legalization of medical cannabis in Canada in 2013, prescription of cannabis for medical purposes has become commonplace and a multibillion dollar industry has formed.
Braden O'Neill, Jacob Ferguson, Lauren Dalueg, Abban Yusuf, Abirami Kirubarajan, Taryn Lloyd, Eisi Mollanji, Navindra Persaud   +7 more
doaj   +1 more source

Effect of Potassium (K) Supply on Cannabinoids, Terpenoids and Plant Function in Medical Cannabis

Agronomy, 2022
We have demonstrated in previous studies that the essential macro-nutrients nitrogen (N) and phosporous (P) have profound effects on the production of cannabinoids and terpenoids in the cannabis plant.
Avia Saloner, N. Bernstein
semanticscholar   +1 more source

An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania

Journal of Primary Care & Community Health, 2022
Introduction/Objectives: Medical cannabis programs across the country vary and differ in their qualifying conditions for medical cannabis use. This has led to a gap in knowledge regarding the specific needs of cannabis patients, including the most common
Debra Kimless, Matthew Caloura, Virginia Markos, Jennie Ryan, Sally Abbonizio, Sharon Janicki   +5 more
doaj   +1 more source

U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020

Annals of Internal Medicine, 2022
BACKGROUND Cannabis policy liberalization has increased cannabis availability for medical or recreational purposes. Up-to-date trends in medical cannabis licensure can inform clinical policy and care.
K. Boehnke, Owen Dean, R. Haffajee, Avinash Hosanagar   +3 more
semanticscholar   +1 more source

New Insights into Cannabis Consumption; Abuses and Possible Therapeutic Effects [PDF]

, 2015
Cannabis is one of the oldest psychotropic drugs known to humanity. The paper assesses the current knowledge on the cannabis, including the mechanisms of action and the therapeutic potential of cannabinoids.
Baconi, Daniela Luiza, Bălălău, Cristian, Vasile, Robert Daniel   +2 more
core   +7 more sources

Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. [PDF]

, 2019
BACKGROUND:Ecological research suggests that increased access to cannabis may facilitate reductions in opioid use and harms, and medical cannabis patients describe the substitution of opioids with cannabis for pain management. However, there is a lack of
Buxton, Jane, Cooper, Ziva D, Kerr, Thomas, Lake, Stephanie, Milloy, MJ, Walsh, Zach, Ware, Mark A, Wood, Evan   +7 more
core   +2 more sources

Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies

BMJ Open, 2022
Objective To establish the prevalence of long-term and serious harms of medical cannabis for chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE, EMBASE, PsycINFO and CENTRAL from inception to 1 April 2020.
D. Zeraatkar, M. Cooper, A. Agarwal, R. Vernooij, G. Leung, Kevin Loniewski, J. Dookie, M. M. Ahmed, B. Hong, Chris J Hong, P. Hong, R. Couban, T. Agoritsas, J. Busse   +13 more
semanticscholar   +1 more source

Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users

Comprehensive Psychiatry, 2020
Background: Regulatory changes are increasing access to both medical cannabis and cannabis in general. As such, understanding patterns of recreational and medical cannabis use is a high public health priority.
Jasmine Turna, Iris Balodis, Catharine Munn, Michael Van Ameringen, Jason Busse, James MacKillop   +5 more
doaj   +1 more source

Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. [PDF]

, 2017
BACKGROUND: Governmental debate in Ireland on the de facto decriminalisation of cannabis and legalisation for medical use is ongoing. A cannabis-based medicinal product (Sativex®) has recently been granted market authorisation in Ireland.
A Bryan, A Charuvastra, AJ Clark, AM Nussbaum, B Kilmer, B Wilsey, Claire Collins, D Bellerose, D Ziemanski, Des Crowley, DI Abrams, DJ Porche, E Kondrad, Eamon Laird, I Bushlin, Ide Delargy, International Centre for Science in Drug Policy, J Rehm, JA McLaren, JB VanGeest, JE Joy, JM Bostwick, M Byrne, MA Ware, Marie Claire Van Hout, MT O’Shea, MT O’Shea, National Advisory Committee on Drugs and Alcohol (NACDA), P Barrett, P Crowley, R Radhakrishnan, RA Sewell, RE Doblin, RH Schwartz, RJ Ellis, RL Pacula, S Schlossarek, S Yuyan, SR Sznitman, SR Sznitman, T Ebert, W Brink van den, W Hall, W Hall, WD Troutt, YWL Chu   +45 more
core   +1 more source

Medical cannabis regulation: an overview of models around the world with emphasis on the Brazilian scenario

Journal of Cannabis Research, 2022
Cannabis sativa has accompanied humankind since ancient times, permeating the most diverse aspects of its existence, among which the search for health promotion and well-being stands out.
M. R. de Souza, A. Henriques, R. Limberger   +2 more
semanticscholar   +1 more source